2013 Society For Laboratory Automation & Screening Annual Meeting, Orlando, FL
Ubiquitination is a post-translational modification process which involves the attachment of ubiquitin(Ub) to lysine residues on either substrate proteins or itself resulting in protein monoubiquitination or polyubiquitination. This modification controls cellular activity by either protein degradation of the polyubiquinated target protein via the proteasome or alterations of signaling processes. Ubiquitination is mediated by the sequential action of three enzymes: the E1 (ubiquitin-activating enzyme(UAE)), E2 (ubiquitin-conjugating enzyme) and E3 (ubiquitin ligase) proteins. Targeting this process has been our focus to develop an anti-cancer drug. Monitoring polyubiquitin expression as a biomarker or pharmacodynamic (PD) marker in cancer cell culture or xenograft models treated with inhibitors of UAE is, therefore, a useful tool to identify a potential therapeutic molecule.
We employed a new technology from Quanterix called Simoa (Single Molecule Array). This technology is capable of ultrasensitive protein measurements for monitoring the inhibition of polyubiquitination using femtoliter microwells to trap antibody captured molecules. Using both tissue culture and mouse xenograft samples and a complementary pair of commercially available antibodies against both linkage specific K48-polyUb and pan-polyUb, we first developed a protocol to establish a standard curve with recombinant K48-polyubiquitinated dihydrofolate reductase (polyUb5-DHFR). We then compared samples treated or untreated with UAE inhibitors from HCT116 and WSU-DLCL2 cell culture as well as the corresponding xenograft tumor lysates to measure changes in poly-K48Ub levels. Our results show that the Simoa technology is significantly more sensitive than other commercially available lysate-based platforms we have evaluated.
Related Posts
Neurology
Comparative Spatial Analyses of the Tumor Immune Landscape in Mouse Models of Glioblastoma Using the PhenoCode Discovery Mouse Neuro Panel and Customized Markers
Poster Background Developing effective therapies for glioblastoma (GBM) relies on robust preclinical animal models that enable detailed investigation of tumor biology, discovery of therapeutic targets, and evaluation of new treatment…
Oncology
Development of a Spatial Metabolic Map of Immunotherapy Sensitive and Resistant Cutaneous Skin Carcinoma
Poster Background Ultrahigh-Plex Single-cell Spatial Phenotyping has revealed valuable insights into the tumor immune microenvironment (TiME) for biomarker discovery and stratification of clinical responses. Metabolic reprogramming is a key hallmark…
Spatial Immunometabolic Profiling of Non-Small Cell Lung Cancer Reveals Distinct Immune Exclusion Patterns and Functional Niches
Analytical validation of a multiplex immunofluorescence 7-Biomarker Immunoprint® assay on the Akoya PhenoImager HT platform for stage I/II Melanoma
Neurology
Neurodegenerative biomarkers in different chambers of the eye relative to plasma: an agreement validation study
Alzheimer’s Research and Therapy | August 26, 2024 Sampani K, Ness S, Tuz-Zahra F, Aytan N, Spurlock EE, Alluri S, Chen X, Siegel NH, Alosco ML, Xia W, Tripodis Y,…
Neurology
Clinical validation of the LucentAD p-Tau 217 as a lab developed test (LDT) for clinical use
Poster The intersection of new therapeutic options for Alzheimer’s disease (AD), the emergence of accurate blood-based tests for AD, and the anticipated health system log jam for confirmatory diagnostic testing…
Neurology
Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice
Alzheimer’s & Dementia | August 3, 2024 Verberk IMW, Jutte J, Kingma MY, Vigneswaran S, Gouda MMTEE, van Engelen MP, Alcolea D, Arranz J, Fortea J, Lleó A, Chevalier C,…
Neurology
Discovering novel plasma biomarkers for ischemic stroke: Lipidomic and metabolomic analyses in an aged mouse model
Journal of Lipid Research | August 2, 2024 Becktel DA, Frye JB, Le EH, Whitman SA, Schnellmann RG, Morrison HW, Doyle KP. J Lipid Res. 2024 https://doi.org/10.1016/j.jlr.2024.100614 Abstract Ischemic stroke…